
    
      Study duration Duration from First visit of first patient (FPFV) to Last visit of last
      patient (LPLV) : 3 years

      Study objectives Primary objective:

      To characterize the disease course in Limb-Girdle Muscular Dystrophy 2I (LGMD2I) patients
      using standardized and disease appropriate evaluations.

      Secondary objectives:

      To identify clinical, imaging and/or laboratory parameters that are indicators of the disease
      course in LGMD2I To identify the best outcome measure for further therapeutics approaches
    
  